Intercell AG · Vienna Austria (Vienna: ICLL)
| Campus Vienna Biocenter 3 | Phone: +43-1-20620-0 |
| Vienna | Fax: +43-1-20620-800 |
| 1030 | |
| Austria | 
Map This Company |
Intercell AG Rankings
Company Description
Intercell AG really wants give the pharmaceutical industry a shot in the arm. The Austrian company develops new vaccinations that aim to invoke strong immune system responses. It sells a travelers vaccine for Japanese encephalitis in areas of Europe, the Asia/Pacific region, and North America. Vaccine development candidates aim to fight staph infections, pandemic influenza, hepatitis C, and other viral and bacterial infections. The company also develops antibody (protein) therapies. Intercell has commercial licensing and co-development agreements with larger companies, including
Intercell AG Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Vienna: ICLL Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 408 |
Executives
15 executives listed for Intercell AG's Vienna, Austria location.
| Chairman | Michel Gréco | |
|---|---|---|
| Vice Chairman | Ernst-Günter Afting | |
| CEO | Gerd Zeittlmeissl |